SPONSOR
Shanghai Pulmonary Hospital, Shanghai, China
Total Trials
8
Recruiting
8
Phases
Phase 4, Phase 2
Conditions studied: MDR-TBImmunotherapyLung CancerPET-CTLung AdenocarcinomaPostoperative Pain, AcuteWhole Slide ImageIASLC Grading SystemArtificial IntelligenceNon-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including MDR-TB, Immunotherapy, Lung Cancer, PET-CT.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Pulmonary Hospital, Shanghai, China
How many clinical trials has Shanghai Pulmonary Hospital, Shanghai, China sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, of which 8 are actively recruiting participants. These trials cover conditions including MDR-TB, Immunotherapy, Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Pulmonary Hospital, Shanghai, China research focus on?
Shanghai Pulmonary Hospital, Shanghai, China clinical trials span MDR-TB, Immunotherapy, Lung Cancer, PET-CT, Lung Adenocarcinoma, and additional conditions. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Pulmonary Hospital, Shanghai, China clinical trial?
To participate in a Shanghai Pulmonary Hospital, Shanghai, China trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Pulmonary Hospital, Shanghai, China trials with current recruitment status updated daily.
Clinical Trials by Shanghai Pulmonary Hospital, Shanghai, China
NCT05493267 Phase 4
Recruiting
A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
MDR-TB
NCT07243873
Recruiting
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
Lung Cancer
NCT04937283
Recruiting
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
NCT07134660
Recruiting
Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
Postoperative Pain, Acute
NCT05925764
Recruiting
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
Lung Adenocarcinoma
NCT06528847 Phase 2
Recruiting
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
Non-Small Cell Lung Cancer
NCT05503667 Phase 2
Recruiting
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage III
NCT06029621
Recruiting
Robot-assisted vs VATS for Thymoma
Thymoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology